Neonatal & Paediatric Pharmacy Group

Neonatal & Paediatric Pharmacy Group is a charity registered with the Charity Commission for England and Wales (charity number 1117648).

Neonatal & Paediatric Pharmacy Group is a registered charity whose purpose is the advancement of education and training in paediatric and neonatal pharmacy, including research and the provision of information and advice for the general public. It supports this work by hosting research awards and providing a support network for colleagues who are starting out in research.

Priority Areas

NPPG’s grant-making supports research and innovation in neonatal and paediatric pharmacy, including the development of educational materials, clinical tools and resources. It also backs the sharing of best practice and evidence-based approaches, and collaborative projects that advance its charitable purposes. Proposals may come from research teams, project groups, organisations and multidisciplinary collaborations in which pharmacy expertise plays a significant role; individuals or groups can propose resource-development projects for open dissemination. Applicants must be NPPG members or work in partnership with the organisation. Its wider educational work supports the specialist neonatal and paediatric pharmacy workforce, and the wider pharmacy and non-pharmacy workforce, to improve pharmaceutical care and safe, effective care for children.

Themes

• Neonatal and paediatric research
• Educational materials
• Clinical tools and resources
• Best practice and evidence

No application process is published in the charity's annual report, its register entry or its website. The contact shown is for getting in touch.

What to send:

• Research project funding
  • Please provide a one-page CV for all applicants including details of recent relevant publications and successful grant applications.
  • The proposed project length must be specified at the time of application.
  • Project costs must be well justified in the application.

What the charity says:

• Collaborative multicentre proposals and submissions from young investigators are encouraged.
• Value for money is important, and project costs must be carefully scrutinised and well justified.
• The work should be likely to lead to significant high-quality peer-reviewed publications.
• Applicants should engage relevant stakeholders, including patients and the public where relevant.
• Grant recipients must account for how funds are used, provide appropriate updates and submit an end-of-project summary or report suitable for publication or sharing with members.